Oncology pharmacists discuss myelofibrosis management, focusing on anemia, JAK inhibitors, and improving patient outcomes through tailored care.
Katherine Tobon, PharmD, BCOP
Advertisement
Articles by Katherine Tobon, PharmD, BCOP
Explore expert insights on managing myelofibrosis, focusing on anemia, JAK inhibitors, and enhancing patient care for better outcomes.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
2
FDA Approves Amivantamab and Hyaluronidase-lpuj, Revolutionizing Lung Cancer Treatment With 5-Minute Subcutaneous Delivery
3
Updates in Treatment of Unresectable Hepatocellular Carcinoma
4
Potential Benefits of GLP-1 Agonists in Reducing Chemotherapy-Related Toxicities in Breast Cancer
5